BioCentury
ARTICLE | Clinical News

Rolofylline: Development discontinued

August 10, 2009 7:00 AM UTC

Merck discontinued development of rolofylline after announcing in June that the compound missed the primary and secondary endpoints in the international Phase III PROTECT trial (see BioCentury, June 8...